DNA methylation of selected tumor suppressor genes in endometrial hyperplasia

Aims. To investigate DNA methylation of specific gene promoters in endometrial hyperplasia compared to normal endometrial tissue. Materials and Methods. To search for epigenetic events, methylation-specific multiplex ligation-dependent probe amplification was employed to compare the methylation stat...

Full description

Bibliographic Details
Main Authors: Ondrej Dvorak, Munachiso Ndukwe, Marcela Slavickova, Jan Laco, Jiri Spacek
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2024-03-01
Series:Biomedical Papers
Subjects:
Online Access:https://biomed.papers.upol.cz/artkey/bio-202401-0009_dna-methylation-of-selected-tumor-suppressor-genes-in-endometrial-hyperplasia.php
_version_ 1797265200683941888
author Ondrej Dvorak
Munachiso Ndukwe
Marcela Slavickova
Jan Laco
Jiri Spacek
author_facet Ondrej Dvorak
Munachiso Ndukwe
Marcela Slavickova
Jan Laco
Jiri Spacek
author_sort Ondrej Dvorak
collection DOAJ
description Aims. To investigate DNA methylation of specific gene promoters in endometrial hyperplasia compared to normal endometrial tissue. Materials and Methods. To search for epigenetic events, methylation-specific multiplex ligation-dependent probe amplification was employed to compare the methylation status of 64 tissue samples with atypical endometrial hyperplasia, 60 tissue samples with endometrial hyperplasia without atypia, and 40 control tissue samples with normal endometrium. Results. Differences in DNA methylation among the groups were found in PTEN, CDH13, and MSH6 promoters (PTEN: atypical hyperplasia 32%, benign hyperplasia 6.8%, normal endometrium 10%; P=0.004; CDH13: atypical hyperplasia, 50%; benign hyperplasia, 43%; normal endometrium 8.1%; P=0.003; MSH6 atypical hyperplasia 84%, benign hyperplasia, 62%; normal endometrium, 52%; P=0.008.) Higher rates of CDH13 promoter methylation were identified in the groups with both forms of endometrial hyperplasia when compared to the control group (atypical hyperplasia, P=0.003, benign hyperplasia, P=0.0002). A higher rate of DNA methylation of the PTEN and MSH6 promoters was observed in samples with atypical endometrial hyperplasia than in samples with benign endometrial hyperplasia (PTEN: P=0.02; MSH6: P=0.01) and samples with normal endometrial tissue (PTEN, P=0.04; MSH6, P=0.006). Conclusion. DNA methylation of CDH13, PTEN, and MSH6 appear to be involved in the development of endometrial hyperplasia.
first_indexed 2024-04-25T00:41:01Z
format Article
id doaj.art-a3ae070db5d1468d9e96c6b5bfbb7f49
institution Directory Open Access Journal
issn 1213-8118
1804-7521
language English
last_indexed 2024-04-25T00:41:01Z
publishDate 2024-03-01
publisher Palacký University Olomouc, Faculty of Medicine and Dentistry
record_format Article
series Biomedical Papers
spelling doaj.art-a3ae070db5d1468d9e96c6b5bfbb7f492024-03-12T09:46:45ZengPalacký University Olomouc, Faculty of Medicine and DentistryBiomedical Papers1213-81181804-75212024-03-011681687310.5507/bp.2022.053bio-202401-0009DNA methylation of selected tumor suppressor genes in endometrial hyperplasiaOndrej Dvorak0Munachiso Ndukwe1Marcela Slavickova2Jan Laco3Jiri Spacek4Department of Obstetrics and Gynecology, University Hospital Hradec Kralove and Faculty of Medicine, Charles University, Hradec Kralove, Czech RepublicDepartment of Obstetrics and Gynecology, University Hospital Hradec Kralove and Faculty of Medicine, Charles University, Hradec Kralove, Czech RepublicDepartment of Clinical Biochemistry and Diagnostics and Osteocenter, University Hospital Hradec Kralove and Faculty of Medicine, Charles University, Hradec Kralove, Czech RepublicThe Fingerland Department of Pathology, University Hospital Hradec Kralove and Faculty of Medicine, Charles University, Hradec Kralove, Czech RepublicDepartment of Obstetrics and Gynecology, University Hospital Hradec Kralove and Faculty of Medicine, Charles University, Hradec Kralove, Czech RepublicAims. To investigate DNA methylation of specific gene promoters in endometrial hyperplasia compared to normal endometrial tissue. Materials and Methods. To search for epigenetic events, methylation-specific multiplex ligation-dependent probe amplification was employed to compare the methylation status of 64 tissue samples with atypical endometrial hyperplasia, 60 tissue samples with endometrial hyperplasia without atypia, and 40 control tissue samples with normal endometrium. Results. Differences in DNA methylation among the groups were found in PTEN, CDH13, and MSH6 promoters (PTEN: atypical hyperplasia 32%, benign hyperplasia 6.8%, normal endometrium 10%; P=0.004; CDH13: atypical hyperplasia, 50%; benign hyperplasia, 43%; normal endometrium 8.1%; P=0.003; MSH6 atypical hyperplasia 84%, benign hyperplasia, 62%; normal endometrium, 52%; P=0.008.) Higher rates of CDH13 promoter methylation were identified in the groups with both forms of endometrial hyperplasia when compared to the control group (atypical hyperplasia, P=0.003, benign hyperplasia, P=0.0002). A higher rate of DNA methylation of the PTEN and MSH6 promoters was observed in samples with atypical endometrial hyperplasia than in samples with benign endometrial hyperplasia (PTEN: P=0.02; MSH6: P=0.01) and samples with normal endometrial tissue (PTEN, P=0.04; MSH6, P=0.006). Conclusion. DNA methylation of CDH13, PTEN, and MSH6 appear to be involved in the development of endometrial hyperplasia.https://biomed.papers.upol.cz/artkey/bio-202401-0009_dna-methylation-of-selected-tumor-suppressor-genes-in-endometrial-hyperplasia.phpmethylationcdh13ptenmsh6endometrial hyperplasiaepigenetics
spellingShingle Ondrej Dvorak
Munachiso Ndukwe
Marcela Slavickova
Jan Laco
Jiri Spacek
DNA methylation of selected tumor suppressor genes in endometrial hyperplasia
Biomedical Papers
methylation
cdh13
pten
msh6
endometrial hyperplasia
epigenetics
title DNA methylation of selected tumor suppressor genes in endometrial hyperplasia
title_full DNA methylation of selected tumor suppressor genes in endometrial hyperplasia
title_fullStr DNA methylation of selected tumor suppressor genes in endometrial hyperplasia
title_full_unstemmed DNA methylation of selected tumor suppressor genes in endometrial hyperplasia
title_short DNA methylation of selected tumor suppressor genes in endometrial hyperplasia
title_sort dna methylation of selected tumor suppressor genes in endometrial hyperplasia
topic methylation
cdh13
pten
msh6
endometrial hyperplasia
epigenetics
url https://biomed.papers.upol.cz/artkey/bio-202401-0009_dna-methylation-of-selected-tumor-suppressor-genes-in-endometrial-hyperplasia.php
work_keys_str_mv AT ondrejdvorak dnamethylationofselectedtumorsuppressorgenesinendometrialhyperplasia
AT munachisondukwe dnamethylationofselectedtumorsuppressorgenesinendometrialhyperplasia
AT marcelaslavickova dnamethylationofselectedtumorsuppressorgenesinendometrialhyperplasia
AT janlaco dnamethylationofselectedtumorsuppressorgenesinendometrialhyperplasia
AT jirispacek dnamethylationofselectedtumorsuppressorgenesinendometrialhyperplasia